RxDoctor Payments Data

Alice Yee, DO

Family Medicine · Greenbrae, CANPI 1194985879

Payments from drug & device makers

$1,580in general payments, 2019–2025

Across 80 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$375
  • Novo Nordisk$164
  • Amgen$155
  • AstraZeneca$153
  • Boehringer Ingelheim$141
  • Lilly USA, LLC$132
  • plus $460 from 12 others

What the payments were for

  • Food & beverage$1,580100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,580 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$131,551
Medicare patients
321
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide16$26,189
SynthroidLevothyroxine Sodium29$2,070
Atorvastatin Calcium113$989
ValacyclovirValacyclovir Hcl24$869
Levothyroxine Sodium60$645
Rosuvastatin Calcium56$571
Bupropion XlBupropion Hcl13$542
Ibandronate Sodium13$517
Simvastatin43$503
Losartan Potassium51$471
Mirtazapine18$467
Azelastine Hcl15$461
Valsartan16$453
Metoprolol Succinate25$399
Ezetimibe15$391

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$164$26,18916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.

Other family medicine in Greenbrae

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →